Skip to content
Baker Capital StrategiesMARKETS. FILINGS. PERSPECTIVE.
Powered by THEMA

Baker Capital Strategies

Free Registration

Register for access to news, tools, alerts and reports.

THEMA Basic included at launch.

Use at least 8 characters.

Home/The Filing Wire/Abbott Laboratories/ 144

SEC Filing · 144

Abbott Laboratories

ABTNYSEEQUITYCurrent

SEC Filing

Filed Aug 25, 2026Accepted Aug 25, 2026, 6:05 PM EDTCIK 1800Accession 0001612571-26-000008
View company →Permanent SEC source ↗
Share

Company context

Abbott is a global healthcare leader that helps people live more fully at all stages of life. Our portfolio of life-changing technologies spans the spectrum of healthcare, with leading businesses and products in diagnostics, medical devices, nutritionals and branded generic medicines. Our 122,000 colleagues serve people in more than 160 countries. Connect with us at www.abbott.com, and on LinkedIn, Facebook, Instagram, X and YouTube.

Current securities

ABTNYSE · EQUITY · Current

Recent company filings

  1. 144 filingSep 2, 2026
  2. Regulation FD Disclosure · Other EventsAug 20, 2026
  3. 144 filingAug 11, 2026
  4. 10-Q filingJul 28, 2026
  5. Results of Operations and Financial ConditionJul 16, 2026

Document unavailable

This filing is not currently available in the archive. Read it on SEC EDGAR ↗